You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

CLINICAL TRIALS PROFILE FOR OXFENDAZOLE


✉ Email this page to a colleague

« Back to Dashboard


Clinical Trials for oxfendazole

Trial ID Title Status Sponsor Phase Summary
NCT01584362 ↗ Single Ascending Dose Safety Study of Oxfendazole Withdrawn School of Veterinary Medicine, Universidad Nacional Mayor de San Marcos Phase 1 This research is being done to learn about the safety in humans of a medicine that is already used in cows and pigs to treat worms. The medicine may be useful for people who have these or other worms. The medicine will be studied first in healthy people, who will be given a very small amount of the medicine once. If the smallest amount of medicine is found to be safe, a slightly higher amount will be given to a new group of volunteers. The highest amount that will be tested is similar to the amount given to animals. If the medicine can be given safely to healthy people in the planned amounts, a later study will be done in people who have worms to see if the medicine kills the worms.
NCT01584362 ↗ Single Ascending Dose Safety Study of Oxfendazole Withdrawn Universidad Peruana Cayetano Heredia Phase 1 This research is being done to learn about the safety in humans of a medicine that is already used in cows and pigs to treat worms. The medicine may be useful for people who have these or other worms. The medicine will be studied first in healthy people, who will be given a very small amount of the medicine once. If the smallest amount of medicine is found to be safe, a slightly higher amount will be given to a new group of volunteers. The highest amount that will be tested is similar to the amount given to animals. If the medicine can be given safely to healthy people in the planned amounts, a later study will be done in people who have worms to see if the medicine kills the worms.
NCT01584362 ↗ Single Ascending Dose Safety Study of Oxfendazole Withdrawn Johns Hopkins Bloomberg School of Public Health Phase 1 This research is being done to learn about the safety in humans of a medicine that is already used in cows and pigs to treat worms. The medicine may be useful for people who have these or other worms. The medicine will be studied first in healthy people, who will be given a very small amount of the medicine once. If the smallest amount of medicine is found to be safe, a slightly higher amount will be given to a new group of volunteers. The highest amount that will be tested is similar to the amount given to animals. If the medicine can be given safely to healthy people in the planned amounts, a later study will be done in people who have worms to see if the medicine kills the worms.
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for oxfendazole

Condition Name

Condition Name
Intervention Trials
Trichuriasis 1
Trichuris Infection 1
Filariasis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH
Intervention Trials
Trichuriasis 3
Helminthiasis 2
Taeniasis 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for oxfendazole

Trials by Country

Trials by Country
Location Trials
United States 3
Peru 1
Tanzania 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State
Location Trials
Iowa 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for oxfendazole

Clinical Trial Phase

Clinical Trial Phase
Clinical Trial Phase Trials
Phase 2 3
Phase 1 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status
Clinical Trial Phase Trials
Not yet recruiting 3
Completed 2
Withdrawn 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for oxfendazole

Sponsor Name

Sponsor Name
Sponsor Trials
National Institute of Allergy and Infectious Diseases (NIAID) 3
Universidad Peruana Cayetano Heredia 2
Johns Hopkins Bloomberg School of Public Health 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type
Sponsor Trials
Other 15
NIH 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.